GlassScriptPhysician profile
Mary Pell Abernathy
NPI 1073559027
$5,105.50
in general payments reported to CMS, 2019-2025
9 companies · $19.93 in 2025
The $19.93 reported for 2025 was less than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.53 · 2020: $4,727 · 2022: $138 · 2023: $74.22 · 2024: $56.72 · 2025: $19.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $4,817.02 | 2019-2020 | |
| Coopersurgical, INC. | $79.67 | 2022-2023 | Paragard T 380a |
| Dexcom, INC. | $62.19 | 2023-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $42.12 | 2022 | |
| Novo Nordisk INC | $31.88 | 2022 | |
| Sanofi Pasteur INC. | $24.80 | 2024 | |
| Astellas Pharma US INC | $19.93 | 2025 | Veozah |
| Minerva Surgical, INC | $15.41 | 2023 | |
| Organon LLC | $12.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Abernathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.